India Glycols Limited (INDIAGLYCO) Fair Value & Analysis
Basic Materials · IN · Market cap ₹72.1B
Fair value as of: Aug 13, 2026
From 16 valuation models · updated 3 days ago
Share price −6.7% over the past month.
Below-average quality, and screening another 49% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (₹704.57). The favourable scenario is already priced in.
- Weak quality (32/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (₹379.38 to ₹704.57) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ₹215.94 – ₹1,184 · fair‑value band ₹379.38 – ₹704.57 · the ₹1,061 price screens above the ₹541.98 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
India Glycols Limited (INDIAGLYCO) currently trades at ₹1,061, while our model-based Fair Value estimate is ₹541.98, implying the stock looks roughly 48.9% overvalued today. The Quality Score stands at 32/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, India Glycols Limited generated revenue of ₹42.1B at a net margin of 7.0%. Revenue grew 13.1% year over year. It earns a return on equity of 11.3%. Net debt stands at ₹16.4B. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹379.38 (bear case) to ₹704.57 (bull case); at ₹1,061, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 12% below its 52-week high and 35% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -60% fair-value upside, at -49%, INDIAGLYCO screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 16 models by family
Widest divergence: Multiples (₹742.53) versus Dividend Discount (₹180.87). Highest evidence: Residual Income (76).
Notify me when INDIAGLYCO reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 35 · Market factors (momentum, volatility) 68
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments.
Full company description
India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. It operates through Bio-based Specialities and Performance Chemicals, Potable Spirits, and Ennature Biopharma segments. The company offers bio mono ethylene, di ethylene, and tri ethylene glycols; ethyl/butyl glycol ethers and acetates, and brake fluids; bio-polymers comprising guar and natural gums; biofuels; specialty chemicals, such as plasticisers, oil fields chemicals, bio-amines, methyl soyate, MDEA and MDEA derivatives, bio-potash granules, and C-Smart specialty products; molasses and grain based extra neutral alcohol; and specialty gases, including industrial and medical oxygen, food grade and industrial carbon dioxide, liquid argon and nitrogen, ethylene oxide, and bio ethylene oxide. It also provides Indian made foreign liquor, such as whiskey under Soulmate Blu and Single Reserve brands; vodka under Amazing brand; and rum under Zumba and Beach House XXX brands, as well as economy spirits under Bunty brand, and branded country liquor. In addition, the company offers natural active pharmaceutical ingredients, nutraceuticals, standardized botanical extracts, and nicotine derivatives. Further, its products find applications in pharma and healthcare; textiles; automotive; personal care; industrial and manufacturing; paints and coatings; oil and gas; food ingredients; packaging; potable spirits; and other various industries. The company also exports its products. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
India Glycols Limited reported revenue of ₹42.1B in FY2026 versus ₹28.7B in FY2022, a compound +10.1%/yr. Reported net income was ₹2.9B in FY2026, compounding −3.7%/yr from FY2022.
INDIAGLYCO screens 49% overvalued. Compare with BASF SE →
Peer Group
Chemicals · 331 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Chemicals median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| BASF SE BASN | 1,034 MXN | 467.04 MXN | -55% |
| PT Barito Pacific Tbk, BRPT | 1,950 IDR | 1,608 IDR | -18% |
| LG Chem, Ltd 051910 | 275,500 KRW | 587,755 KRW | +113% |
| SRF Limited 503806 | ₹2,609 | ₹749.17 | -71% |
| 542812 542812 | ₹4,709 | ₹791.05 | -83% |
| Navin Fluorine International Limited NAVINFLUOR | ₹8,357 | ₹2,146 | -74% |
| 506285 506285 | ₹4,048 | ₹1,589 | -61% |
| Kansai Nerolac Paints Limited 500165 | ₹209.25 | ₹80.51 | -62% |
| Deepak Nitrite Limited DEEPAKNTR | ₹1,718 | ₹679.17 | -60% |
| KCC Corporation 002380 | 454,000 KRW | 1,763,304 KRW | +288% |
Compare India Glycols Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is India Glycols Limited (INDIAGLYCO) overvalued or undervalued?
What is the fair value of INDIAGLYCO?
What is the quality score of INDIAGLYCO?
What is the revenue of India Glycols Limited (INDIAGLYCO)?
What is the net profit margin of INDIAGLYCO?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track India Glycols Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.